The American Society of Regional Anesthesia and Pain Medicine (ASRA) is one of the largest subspecialty medical societies in anesthesiology with more than 5,000 members in 66 countries on 6 continents.
Their mission is to advance the science and practice of regional anesthesia and pain medicine to improve patient outcomes through research, education, and advocacy.
The 2019 event provided delegates with 3 days of the latest updates in the fields of regional anesthesia and acute pain with many leading experts delivering workshops and presentations, alongside highly interactive sessions including problem-based learning discussions.
ASRA 2020 looks set to be equally valuable and insightful, bringing together dynamic experts and delegates, exhibitors and educational resources.
ANNOUNCEMENT [4th Feb 2020]: Medovate to formerly launch new product as a silver sponsor of ASRA 2020
Medovate will formerly be launching SAFIRA (SAFer Injection for Regional Anaesthesia) in the US at ASRA 2020 as a silver sponsor of the event. At ASRA 2020, US clinicians will have their first opportunity to see Medovate’s SAFIRA in action. As silver sponsors of the conference, Medovate will be running demonstrations and allowing experts in regional anaesthesia and pain medicine to view the device up close, as well as being introduced to Medovate’s US-based distributors.
More about the event can be found on the ASRA website.